Guided Therapeutics (GTHP) EBT Margin Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -419.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 110.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -300.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -287.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 233.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 772.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -464.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 584.00
10 Guided Therapeutics - - 458,000.00 6.50 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 6.50 Mn
Dec 31, 2024 -6.40 Mn
Mar 31, 2024 -275,000.00
Jun 30, 2023 1.50 Mn
Mar 31, 2023 619,000.00
Sep 30, 2022 -3.71 Mn
Jun 30, 2022 3.32 Mn
Dec 31, 2021 -940,400.00
Sep 30, 2021 -168,756.00
Dec 31, 2020 189,525.00
Sep 30, 2020 1.46 Mn
Dec 31, 2019 1.33 Mn
Sep 30, 2019 2.47 Mn
Jun 30, 2019 -30.91 Mn
Mar 31, 2019 -2.82 Mn
Dec 31, 2018 163,591.00
Sep 30, 2018 -3.01 Mn
Jun 30, 2018 4.40 Mn
Mar 31, 2018 2.76 Mn
Dec 31, 2017 -857,807.00
Sep 30, 2017 -694,456.00
Dec 31, 2016 1.99 Mn
Sep 30, 2016 2.72 Mn
Dec 31, 2015 -14.70 Mn
Sep 30, 2015 -1.39 Mn
Jun 30, 2015 250,364.00
Mar 31, 2015 -1.65 Mn
Dec 31, 2014 12.68 Mn
Sep 30, 2014 -1.52 Mn
Jun 30, 2014 -2.04 Mn
Mar 31, 2014 713,423.00
Dec 31, 2013 52,230.00
Sep 30, 2013 152,981.00
Jun 30, 2013 91,583.00
Mar 31, 2013 94,574.00
Dec 31, 2012 -19,085.00
Sep 30, 2012 -11,835.00
Jun 30, 2012 -18,187.00
Mar 31, 2012 4,643.00
Jun 30, 2011 11,681.00